OPA Addictions Conference (Virtual Format)
2020-11-27 01:00 PM 2020-11-28 02:30 PM OPA Addictions Conference (Virtual Format) Virtual Event America/New_York

Organization: OPA

Conference Chairs:

Conference Planning Committee:

Valerie Primeau, Wiplove Lamba, Angela Ho, Mike Franklyn, Ben Joseph

Learning Objectives:

Upon attending the day, attendees will be able to: 

  1. Compare and describe current evidence-based pharmacotherapy options for people who use substances in both the withdrawal and maintenance phase, including opiate agonist treatment and anti-craving medications
  2. Compare and describe psychotherapy principles and available psychosocial treatments for people who use substances
  3. Engage in a discussion around various treatment approaches for complex patients presenting with concurrent disorders

This one-credit-per-hour Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by the Continuing Education and Professional Development Office at the Northern Ontario School of Medicine for up to 7 Mainpro+ credit(s).

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Continuing Education and Professional Development Office at the Northern Ontario School of Medicine. You may claim a maximum of 7 hour(s) (credits are automatically calculated).


November 27, 2020 - 13:00 - 17:00 (3.5 hours):
Pharmacotherapy Primer for the Treatment of Substance Use Disorders
+/-
  • 13:00 – 15:00: Management of Alcohol Use Disorder (AUD) and other Substance Use Disorders (SUDs)
  • 15:00 – 15:30: Break
  • 15:30 – 17:00: Management of Opioid Use Disorder (OUD)

PRESENTERS: Dr. Valerie Primeau and Dr. Wiplove Lamba

SESSION OBJECTIVES:
By the end of this session, the participant will be able to:

  1. Identify the importance of diagnosing and treating Substance Use Disorders
  2. Describe the indications, benefits and potential adverse effects of the most common pharmacological agents to treat Substance Use Disorders
  3. Apply current principles for withdrawal management of common substances
  4. Appreciate the value in using an integrated approach in the treatment of concurrent disorders

November 28, 2020 10:00 - 14:30 (3.5 hours):
Introduction to Psychosocial Approaches for the Treatment of Substance Use Disorders
+/-
  • 10:00 – 12:00: Overview of individual psychotherapy treatment options 
  • 12:00 – 13:00: Lunch break
  • 13:00 – 14:30: Overview of residential treatment and provincial resources

PRESENTERS: Dr. Valerie Primeau and Dr. Wiplove Lamba

SESSION OBJECTIVES:
By the end of this session, the participant will be able to:

  1. Understand the general psychotherapeutic approaches to the treatment of concurrent disorders and the importance of trauma-informed care
  2. Describe and learn common Motivational Interviewing techniques used in the treatment of Substance Use Disorders
  3. Appreciate the value in using an integrated approach in the treatment of concurrent disorders and list resources available in Ontario for the assessment and treatment of substance use disorders

PRESENTERS:

Valerie Primeau, MD, FRCPC is a bilingual psychiatrist in North Bay. She has been actively involved in the treatment of concurrent disorders. She is the physician lead for the implementation of medically-supervised withdrawal management at the North Bay Regional Health Centre and the rural implementation of the Centre for Addiction and Mental Health (CAMH) Integrated Care Pathway on alcohol use disorder and depression. She also provides physician leadership at the Rapid Access Addiction Medicine (RAAM) clinic at the Community Counselling Centre of Nipissing. She was a member of the Ontario Health Alcohol Use Disorder Quality Standard Advisory Committee and is helping revise the Withdrawal Management Standards with Addictions and Mental Health Ontario. She sits on the Executive Committee of the Ontario Psychiatric Association and is actively involved in resident education. She is currently the North Bay Co-Site Director and Psychotherapy Coordinator for the Northern Ontario School of Medicine (NOSM) Psychiatry Residency Program.

Wiplove Lamba, MD, FRCPC, Dip ABAM, ISAM C, DAPN is an addiction psychiatrist at the University of Toronto and a psychiatrist at Ontario Shores for Mental Health Sciences. He is a lecturer in the department of Anesthesia and a part time clinical assistant professor in the department of psychiatry.  He has given over 20 workshops at the national level and numerous more at the local and provincial levels in helping people build skills in working with those who use substances.

He is the regional co-director of Ontario for the Canadian Society of Addiction Medicine and the medical co-lead of ECHO Ontario Addiction Medicine and Psychosocial interventions. He is a member of the motivational interviewing network of trainers. He is excited to work with all of you in teaching and learning together how to best approach people who use substances.  


HOW TO REGISTER

REGISTER NOW


© 2020 Ontario Psychiatric Association
Privacy Policy
^